We're jiangsu East-Mab biomedical technology co., ltd. Our Chinese name is 江苏东抗生物、jiangsu Dongkang biomedical technology co., ltd. There are more than 90 employees including 5 PhD in biology and 16 biological masters in our company until June 2023. We have quality control system that has passed ISO9001 certification in 2020, and the ISO 13485 certification is in progress by SGS. Founded by a team of senior experts in the biomedical industry in 2016. We based in Nantong city, Jiangsu province, China. Currently, we have two R & D and production bases in Suzhou city and Nantong city.We have a sales team in Beijing City. We focus on the production of in vitro diagnostic proteins, target proteins, industrial enzymes and cytokines. The company is a national high-tech enterprise and has passed the ISO9001 international quality system certification. The company has 7500 square meters of GMP standard protein production workshop, 4000 square meters of research and development laboratory, and protein expression platform based on Escherichia coli, yeast and mammalian cells (CHO/HEK293). At the same time, the company also has single-cell (human, mouse, rat, rabbit, alpaca, camel, monkey) antibody/all-natural humanized technology platform, bispecific antibody technology platform, antibody glycosylation (fucose knockout) And antibody modification technology platform, nano-antibody technology platform, with raw protein/antibody modification related technology patents and 16 soft works. The company is positioned as a manufacturer of core protein raw materials in the biomedical industry. It will continue to maintain technology and market investment, adhere to the concept of "responsibility, focus, innovation, and development", meticulous and refined attitude, with a professional R & D team and first-class hardware supporting facilities.